[Clinical features of pediatric multiple sclerosis: epidemiology and treatment]

Insights

Pediatric multiple sclerosis (MS) shares adult characteristics but can be misdiagnosed as acute disseminated encephalomyelitis (ADEM). This review examines pediatric MS clinical features in Japan and globally.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Demyelinating Diseases

Context:

  • Multiple sclerosis (MS) in children presents diagnostic challenges, often overlapping with other demyelinating conditions.
  • Acute disseminated encephalomyelitis (ADEM) and other infectious encephalitides can mimic pediatric MS, particularly in younger children.
  • Distinguishing pediatric MS from ADEM is crucial for accurate diagnosis and management.

Purpose:

  • To review the clinical features of pediatric multiple sclerosis (MS) in Japan.
  • To compare pediatric MS characteristics in Japan with international findings.
  • To elucidate the diagnostic difficulties in differentiating pediatric MS from other demyelinating diseases like ADEM.

Summary:

  • Pediatric MS shares core features with adult MS but poses diagnostic challenges due to similarities with ADEM.
  • A nationwide survey in Japan and international data were analyzed to understand pediatric MS clinical presentations.
  • Findings highlight the need for careful evaluation to distinguish MS from other childhood demyelinating disorders.

Impact:

  • Improved understanding of pediatric MS clinical phenomenology in Japan.
  • Enhanced diagnostic criteria for differentiating pediatric MS from ADEM.
  • Foundation for future research into the specificities of MS in pediatric populations.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
4
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
4